EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure. AHA2021

EMPULSE TRIAL. EMPAGLIFLOZIN in patients with acute decompensated heart failure. EMPAGLIFLOZIN is one of the SGLT2 inhibitors.

SGLT2 inhibitors are the new drugs which have been approved for heart failure with reduced ejection fraction (HFrEF). After the landmark EMPA-REG_OUTCOME, DECLARE TIMI 58, EMPEROR REDUCED and DAPA HF trials, empagliflozin and dapagliflozin have found a place in the management of HFrEF or heart failure. Lets discover what makes them special drugs in heart failure.

#heart
#cad
#heartfailure #aha
#cardioed
#cardio
#cardiologist #cardiologia #cardiologie #cardiovascular
Here are some other discussions on SGLT2 inhibitors.
SGLT2 inhibitors in heart failure.
https://youtu.be/T5Zhof_6-3Q

Canagliflozin in heart failure.
https://youtu.be/q3G4Gf_swts

EMPEROR PRESERVED TRIAL
https://youtu.be/Zq4fprAcQPI
Cardio Ed Podcast is available on Spotify, Apple Podcast, Google Podcast, Stitcher, Amazon Music & all popular podcast platforms. Here are the links.
Apple
https://podcasts.apple.com/us/podcast/cardio-ed/id1570745864

Google Podcast
https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy81ZDRiOTgwMC9wb2RjYXN0L3Jzcw

Spotify:
https://open.spotify.com/show/3SLQ2g4Ii8hdFiy7i8LMRp?si=hWgPgwliQ5a5RY_nz-Q22g&utm_source=copy-link

Amazon Music
https://music.amazon.in/podcasts/4215cfdf-5121-438e-b355-14eaabed41e5/CARDIOED?ref=dm_sh_vn5xvDArGZGRCTh8YpK3Mdtff

Видео EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure. AHA2021 канала Cardio-Ed